Research output per year
Research output per year
Personal profile
Education/Academic qualification
PhD, Ben-Gurion University of the Negev
1 Oct 2017 → 1 Oct 2020
Award Date: 1 Oct 2020
Bachelor, Open University of Israel
1 Oct 2013 → 1 Oct 2016
Award Date: 1 Oct 2016
PhD, Tel Aviv University
1 Oct 2005 → 1 Oct 2009
Award Date: 1 Jun 2010
Bachelor, Tel Aviv University
1 Oct 2002 → 1 Oct 2005
Award Date: 1 Oct 2005
External positions
Post-Doctorate, Harvard University
1 Nov 2020 → 30 Oct 2021
Head of Epidemiology & Research, Clalit Research Institute
1 Nov 2016 → …
Fingerprint
Dive into the research topics where Noam Barda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel
Waxman, J. G., Makov-Assif, M., Reis, B. Y., Netzer, D., Balicer, R. D., Dagan, N. & Barda, N., 1 Dec 2022, In: Nature Communications. 13, 1, 2202.Research output: Contribution to journal › Article › peer-review
Open Access -
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)
Katz, M. A., Harlev, E. B., Chazan, B., Chowers, M., Greenberg, D., Peretz, A., Tshori, S., Levy, J., Yacobi, M., Hirsch, A., Amichay, D., Weinberger, R., Dor, A. B., Taraday, E. K., Reznik, D., Chayat, C. B., Sagas, D., Zvi, H. B., Berdinstein, R., Rashid, G. & 9 others, , 24 Jan 2022, In: Vaccine. 40, 3, p. 512-520 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting
Mittelman, M., Magen, O., Barda, N., Dagan, N., Oster, H. S., Leader, A. & Balicer, R., 10 Mar 2022, In: Blood. 139, 10, p. 1439-1451 13 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Improving Cardiovascular Disease Prediction Using Automated Coronary Artery Calcium Scoring from Existing Chest CTs
Barda, N., Dagan, N., Stemmer, A., Yuval, J., Bachmat, E., Elnekave, E. & Balicer, R., 1 Jan 2022, (Accepted/In press) In: Journal of Digital Imaging.Research output: Contribution to journal › Article › peer-review
-
Indirect protection of children from SARS-CoV-2 infection through parental vaccination
Hayek, S., Shaham, G., Ben-Shlomo, Y., Kepten, E., Dagan, N., Nevo, D., Lipsitch, M., Reis, B. Y., Balicer, R. D. & Barda, N., 27 Jan 2022, (E-pub ahead of print) In: Science. 375, 6585, p. eabm3087 5 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Previously undiagnosed cancer in patients with arterial thrombotic events – A population-based cohort study
Leader, A., Dagan, N., Barda, N., Goldberg, I., Raanani, P., Spectre, G., Balicer, R. & Gafter-Gvili, A., 1 Mar 2022, In: Journal of Thrombosis and Haemostasis. 20, 3, p. 635-647 13 p.Research output: Contribution to journal › Article › peer-review
-
Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older
Auster, O., Finkel, U., Dagan, N., Barda, N., Laufer, A., Balicer, R. D. & Ben-Shachar, S., 1 Apr 2022, In: JAMA network open. 5, 4, p. e227657Research output: Contribution to journal › Article › peer-review
Open Access -
The association between real-time reverse transcriptase polymerase chain reaction cycle threshold values, symptoms and disease severity among COVID-19 patients in the community: a retrospective cohort study
Makov-Assif, M., Krispin, S., Ben-Shlomo, Y., Holander, T., Dagan, N., Balicer, R. & Barda, N., 1 Jan 2022, In: Infectious Diseases. 54, 3, p. 205-212 8 p.Research output: Contribution to journal › Article › peer-review
-
The role of observational studies based on secondary data in studying SARS-CoV-2 vaccines
Barda, N. & Dagan, N., 1 Mar 2022, In: Clinical Microbiology and Infection. 28, 3, p. 313-314 2 p.Research output: Contribution to journal › Comment/debate
Open Access -
Validation of Heart Failure-Specific Risk Equations in 1.3 Million Israeli Adults and Usefulness of Combining Ambulatory and Hospitalization Data from a Large Integrated Health Care Organization
Khan, S. S., Barda, N., Greenland, P., Dagan, N., Lloyd-Jones, D. M., Balicer, R. & Rasmussen-Torvik, L. J., 1 Jan 2022, (Accepted/In press) In: American Journal of Cardiology. 168, p. 105-109 5 p.Research output: Contribution to journal › Article › peer-review
Press / Media
-
Third BNT162b2 Vaccine Dose May Reduce Severe COVID-19 Outcomes
22/11/21
1 item of Media coverage
Press/Media
-
Third BNT162b2 Vaccine Dose May Cut Severe COVID-19 Outcomes
5/11/21 → 11/11/21
3 items of Media coverage
Press/Media
-
Third BNT162b2 vaccine dose may cut severe COVID-19 outcomes
5/11/21
1 item of Media coverage
Press/Media
-
Studie zur Booster-Impfung: So wirksam schützt die dritte Dosis
2/11/21
1 item of Media coverage
Press/Media
-
Maßnahmen gegen die vierte Welle: Wie wirksam schützt die Booster-Impfung?
1/11/21
1 item of Media coverage
Press/Media
-
COVID-19 Vaccine Effectiveness Against the Delta Variant in Adolescents
1/11/21
1 item of Media coverage
Press/Media
-
Booster vaccine dose effective in reducing severe covid-19-related outcomes: Lancet study
1/11/21
1 item of Media coverage
Press/Media
-
Largest Real-World Study Of Third Dose Of COVID-19 Vaccine Effectiveness
30/10/21 → 31/10/21
4 items of Media coverage
Press/Media